arrow
A

Anna Aagaard

astrazeneca
H指数:27
被引数:1,891
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Mineralocorticoid Receptor Antagonists With an Acylurea as a Key Polar Interaction Motif

以酰脲为关键极性相互作用基团的盐皮质激素受体拮抗剂

2026-04-300
PRE
Identification and optimisation of a pyrimidopyridone series of IRAK4 inhibitors

嘧啶并吡啶酮系列IRAK4抑制剂的鉴定和优化

2022-06-012
PRE
AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2
2021-08-3111
PRE
Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors
2020-12-014
PREAI
Discovery of Potent and Orally Bioavailable Inverse Agonists of the Retinoic Acid Receptor-Related Orphan Receptor C2
2019-05-2921
OAAI
Identification of Mineralocorticoid Receptor Modulators with Low Impact on Electrolyte Homeostasis but Maintained Organ Protection
2018-12-3119
PREAI
Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based Design
2018-08-1031
PREAI
Engineering the surface properties of a human monoclonal antibody prevents self-association and rapid clearance in vivo
2016-12-20107
OAAI
Structure-Based Drug Design of Mineralocorticoid Receptor Antagonists to Explore Oxosteroid Receptor Selectivity

基于结构的盐皮质激素受体拮抗剂药物设计探索氧类固醇受体选择性

2016-12-1511
OAAI